BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 7379916)

  • 21. Analgesia and ptosis caused by caerulein and cholecystokinin octapeptide (CCK-8).
    Zetler G
    Neuropharmacology; 1980 May; 19(5):415-22. PubMed ID: 6248810
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect of caerulein on the exocrine pancreas function in man; examinations of dose effects and comparisons with the effect of cholecystokinin/pankreozymin (author's transl)].
    Otte M; Forell MM
    Klin Wochenschr; 1979 Aug; 57(15):789-92. PubMed ID: 491501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pure cholecystokinin: pancreatic protein and bicarbonate response.
    Debas HT; Grossman MI
    Digestion; 1973; 9(6):469-81. PubMed ID: 4787845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The action of caerulein on pancreatic secretion of the dog and biliary secretion of the dog and the rat.
    Bertaccini G; De Caro G; Endean R; Erspamer V; Impicciatore M
    Br J Pharmacol; 1969 Sep; 37(1):185-97. PubMed ID: 5824930
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of gastrin and gastrin analogues on pancreatic acinar cell membrane potential and resistance.
    Iwatsuki N; Kato K; Nishiyama A
    Br J Pharmacol; 1977 May; 60(1):147-54. PubMed ID: 884386
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison between the synthetic cholecystokinin analogues caerulein and Thr28NlE31CCK25-33(CCK9) with regards to plasma bioactivity, degradation rate and stimulation of pancreatic exocrine function.
    Mössner J; Sprenger C; Secknus R; Kestel W; Fischbach W
    Z Gastroenterol; 1991 Feb; 29(2):59-64. PubMed ID: 1714671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of vasoactive intestinal peptide and secretin in stimulation of pancreatic secretion.
    Konturek SJ; Pucher A; Radecki T
    J Physiol; 1976 Feb; 255(2):497-509. PubMed ID: 1255530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anticonvulsant effects of caerulein, cholecystokinin octapeptide (CCK-8) and diazepam against seizures produced in mice by harman, thiosemicarbazide and isoniazid.
    Zetler G
    Neurosci Lett; 1981 Jul; 24(2):175-80. PubMed ID: 6265841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Central depressant effects of caerulein and cholecystokinin octapeptide (CCK-8) differ from those of diazepam and haloperidol.
    Zetler G
    Neuropharmacology; 1981 Mar; 20(3):277-83. PubMed ID: 6267504
    [No Abstract]   [Full Text] [Related]  

  • 30. Cholecystokinin receptor antagonism by peptidergic and non-peptidergic agents in rat pancreas.
    Dembinski A; Jaworek J; Konturek PK; Konturek SJ; Warzecha Z
    J Physiol; 1989 Apr; 411():419-35. PubMed ID: 2614728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Secretion of electrolytes by the pancreas of the anaestetized rat.
    Sewell WA; Young JA
    J Physiol; 1975 Nov; 252(2):379-96. PubMed ID: 1206529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Action of cholecystokinin analogues on exocrine and endocrine rat pancreas.
    Otsuki M; Okabayashi Y; Ohki A; Oka T; Fujii M; Nakamura T; Sugiura N; Yanaihara N; Baba S
    Am J Physiol; 1986 Apr; 250(4 Pt 1):G405-11. PubMed ID: 2421584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of cholecystokinin-like peptides on rearing activity and hexobarbital-induced sleep.
    Zetler G
    Eur J Pharmacol; 1980 Aug; 66(1):137-9. PubMed ID: 6250861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of pancreatic polypeptide and its C-terminal hexapeptide on meal and secretin induced pancreatic secretion in dogs.
    Chance RE; Cieszkowski M; Jaworek J; Konturek SJ; Swierczek J; Tasler J
    J Physiol; 1981 May; 314():1-9. PubMed ID: 7310683
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and biological activity of some partially modified retro-inverso analogues of cholecystokinin.
    Rodriguez M; Galas MC; Lignon MF; Mendre C; Laur J; Aumelas A; Martinez J
    J Med Chem; 1989 Oct; 32(10):2331-9. PubMed ID: 2477546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sedative action of cholecystokinin octapeptide on behavioral excitation by thyrotropin releasing hormone and methamphetamine in the rat.
    Katsuura G; Itoh S
    Jpn J Physiol; 1982; 32(1):83-91. PubMed ID: 6281507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of cholecystokinin and caerulein on gastric emptying.
    Anika MS
    Eur J Pharmacol; 1982 Nov; 85(2):195-9. PubMed ID: 6897537
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The effect of caerulein or cholecystokinin on pancreatic endocrine and exocrine secretion in the isolated perfused rat pancreas (author's transl)].
    Sakamoto C
    Nihon Naibunpi Gakkai Zasshi; 1980 Sep; 56(9):1200-13. PubMed ID: 6160065
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparative effects of CCK receptor antagonists on rat pancreatic secretion in vivo.
    Niederau M; Niederau C; Strohmeyer G; Grendell JH
    Am J Physiol; 1989 Jan; 256(1 Pt 1):G150-7. PubMed ID: 2463767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Xenopsin stimulates exocrine pancreatic secretion in the dog.
    Feurle GE; Baća I; Knauf W; Schwab A; Araki T; Carraway R
    Experientia; 1982 Jun; 38(6):679-80. PubMed ID: 7106235
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.